+1 (817) 546-4770

EU Recommends Merck COVID-19 Pill for Adults at Risk of Severe Illness

Academic Anxiety?

Get an original paper within hours and nail the task

156 experts online

(Reuters) – The European Union’s drug regulator on Friday advised that an experimental COVID-19 pill from Merck should be given within five days of first symptoms to treat adults who do not need oxygen support and are at risk of their disease worsening.The European Medicines Agency (EMA) said the pill, a ribonucleoside analog developed along with Ridgeback Biotherapeutics, should be taken twice a day for five days, but advised against use during pregnancy for in women who plan to get pregnant.webmd.ads2.defineAd({id:’ads-pos-1122′,pos: 1122});”EMA issued this advice to support national authorities who may decide on possible early use of the medicine prior to marketing authorisation … in light of rising rates of infection and deaths due to COVID-19 across the EU,” it said.EMA began a rolling review of the Merck tablet, Lagevrio, last month, and on Friday also started looking at data on a rival protease inhibitor pill from Pfizer Inc to make recommendations on its use, like that for Merck’s, before wider approvals.

webmd.ads2.defineAd({id:’ads-pos-520′,pos: 520});The regulator on Friday also said that breastfeeding must also be stopped around the time of treatment with Merck’s Lagevrio.

webmd.ads2.defineAd({id:’ads-pos-1520′,pos: 1520});

3

Reuters Health Information © 2021 

TOP PICKS FOR YOU

webmd.ads2.defineAd({
id: ‘ads-pos-904’,
pos: 904
});

webmd.ads2.defineAd({
id: ‘ads-pos-906’,
pos: 906
});

webmd.ads2.defineAd({
id: ‘ads-pos-907’,
pos: 907
});

Need an essay written specifically to meet your requirements?

Choose skilled experts on your subject and get an original paper within your deadline

156 experts online

Your time is important. Let us write you an essay from scratch

Tips and Tricks from our Blog

11174 Introduction To Management

Free Samples 11174 Introduction To Management .cms-body-content table{width:100%!important;} #subhidecontent{ position: relative; overflow-x: auto; width: 100%;} 11174 Introduction

Read More »